Journals / Türk Pediatri Arşivi / 2018 / Cilt: 53 - Sayı: 2

Benign transient hyperphosphatasemia in an infant during zinc supplementation

Çinko kullanımı sırasında selim geçici hiperfosfatazemi gelişen bir olgu

Pages
120–123
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here, we report an infant who was diagnosed as having benign transient hyperphosphatasemia based on clinical and laboratory findings who had increased alkaline phosphatase levels during zinc supplementation, with the aim of highlighting benign transient hyperphosphatasemia in infancy and childhood.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Benign transient hyperphosphatasemia is characterized by a significant increase in alkaline phosphatase levels, which is detected incidentally in infancy and children without underlying bone and liver disease.
📊
Key Findings & Data:This condition is a biochemical disorder rather than a clinical disorder and resolves within a short duration.
💡
Conclusion & Impact:Here, we report an infant who was diagnosed as having benign transient hyperphosphatasemia based on clinical and laboratory findings who had increased alkaline phosphatase levels during zinc supplementation, with the aim of highlighting benign transient hyperphosphatasemia in infancy and childhood.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Benign transient hyperphosphatasemia is characterized by a significant increase in alkaline phosphatase levels, which is detected incidentally in infancy and children without underlying bone and liver disease. This condition is a biochemical disorder rather than a clinical disorder and resolves within a short duration. Recognition of this entity by pediatricians is important to avoid unnecessary investigations. Here, we report an infant who was diagnosed as having benign transient hyperphosphatasemia based on clinical and laboratory findings who had increased alkaline phosphatase levels during zinc supplementation, with the aim of highlighting benign transient hyperphosphatasemia in infancy and childhood.

Özet

Selim geçici hiperfosfatazemi, süt çocuğu ve çocuklarda altta yatanbir kemik ya da karaciğer hastalığı yokluğunda, rastlantısal olaraksaptanan ve kısa sürede normale dönen alkalen fosfataz enzimininaşırı artışıyla özgün bir biyokimyasal sorundur. Bu durumun çocukhekimleri tarafından bilinmesi, süt çocuklarında klinik bulgu yokluğunda saptanan aşırı yüksek alkalen fosfataz düzeyleri karşısında gereksiz endişe duyulmasını ve buna bağlı aşırı tetkik yapılmasını önleyecektir. Burada çinko desteği alımı sırasında yüksek alkalen fosfatazdüzeyi saptanan, klinik ve laboratuvar bulgularına dayanılarak selimgeçici hiperfosfatezemi tanısı alan bir süt çocuğu olgusu sunularakselim geçici hiperfosfatazemi sorununa dikkat çekilmek istenmiştir

🔖

Cite This Article

Tütüncüler, F., Arifoğlu, İ., Yıldırım, A., Sönmez, A. B. (2022). Benign transient hyperphosphatasemia in an infant during zinc supplementation. Türk Pediatri Arşivi, Cilt: 53 - Sayı: 2, 120–123. https://ajindex.com/articles/641054

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Tolaymat N, de Melo MC. Benign transient hyperphosphatasemia of infancy and childhood. South Med J 2000; 93: 1162-4. [CrossRef ] 2. Carroll AJ, Coakley JC. Transient hyperphosphatasaemia: an important condition to recognize. J Paediatr Child Health 2001; 37: 359-62. [CrossRef ] 3. Kutilek S, Bayer M. Transient hyperphosphatasemia– where do we stand? Turk J Pediatr 1999; 41: 151-60. 4. Crofton PM. What is the cause of benign transient hyperphosphatasemia? A study of 35 cases. Clin Chem 1988; 34: 335-40. 5. Suzuki M, Okazaki T, Nagai T, Töro K, Setonyi P. Viral infection of infants and children with benign transient hyperphosphatasemia. FEMS Immunol Med Microbiol 2002; 33: 215-8. [CrossRef ] 6. Teitelbaum JE, Laskowski A, Barrows FP. Benign transient hyperphosphatasemia in infants and children: a prospective cohort. J Pediatr Endocrinol Metab 2011; 24: 351-3. [CrossRef ] 7. Dori N, Levi L, Stam T, Sukhotnik I, Shaoul R. Transient hyperphosphatasemia in children revisited. Pediatr Int 2010; 52: 866-71. [CrossRef ] 8. Gualco G, Lava SA, Garzoni L, et al. Transient benign hyperphosphatasemia. J Pediatr Gastroenterol Nutr 2013; 57: 167-71. [CrossRef ] 9. Huh SY, Feldman HA, CoxJE, Gordon CM. Prevalence of transient hyperphosphatasemia among healthy infants and toddlers. Pediatrics 2009; 124: 703-9. [CrossRef ] 10. Rocha ED, de Brito NJ, Dantas MM, Silva Ade A, Almeida Md, Brandeo- Neto J. Effects of zinc supplementation on GH, IGF1, IGFBP3, OCN, and ALP in zinc-deficient children. J Am Coll Nutr 2015; 34: 290-9. [CrossRef ]